Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Ophthalmology Devices and Drugs Market (Contact Lens, OCT Scanner, IOL, Dry Eye, AMD, Glaucoma) Competitive Landscape & Global Forecasts To 2017
1. Ophthalmology Devices and Drugs Market (Contact Lens, OCT
Scanner, IOL, Dry Eye, AMD, Glaucoma) Competitive
Landscape & Global Forecasts To 2017
Report Details:
Published:July 2012
No. of Pages: 517
Price: Single User License – US$4650
The global ophthalmology market witnessed a dip during the economic downturn in 2008 and
2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population,
large pool of patients with eye diseases, changing demographics and geographical trends, and
increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and
cataract are increasing every year.
Cataract is responsible for 48% of the population becoming totally blind. In addition, more than 60
million people suffer from glaucoma and this number is expected to reach 80 million by 2020. An
increasing aging population is also resulting in more people suffering from refractive errors. It is
estimated that in the U.S. and Europe, refractive errors affect more than 30% of the population
aged 40 or older. However, the economic slowdown and drying pipeline of ophthalmology drugs is
restricting the market.
The ophthalmology drugs and devices market is divided into four major segments, namely,
surgical devices, diagnostic and monitoring devices, vision care, and drugs. The devices market is
divided into applications like surgery and diagnostics. Drugs market is classified into existing
treatment drugs and drugs in pipeline and the vision care market is segmented into spectacles and
contact lenses. The total market is forecasted till 2017. This market is also considered by
formulation types such as capsules, gels, eye drops, ointment, and eye solutions.
Advancements in technologies, high prevalence rates of refractive error, cataract, and glaucoma,
increasing demand for the diagnostic procedures and low compliance with pharmaceuticals will
propel the devices market. However, lack of awareness of diseases like glaucoma hinders the
growth of this market. The drugs market will grow at a slower pace mainly due to the combined
effect of loss of patent protection for several drugs and drying pipeline.
The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest
2. of the world (RoW). North America is the largest market for ophthalmology drugs and devices,
followed by Europe and Asia. North America and Europe is expected to grow at a slower pace,
primarily due to the economic slowdown and saturation in these markets. APAC is an unsaturated
market, especially China and India, and these regions are expected to drive the growth of the
overall ophthalmology market, mainly due to growing awareness of eye diseases and increasing
disposable income.
Scope of the report
The research report categorizes the global ophthalmology drugs and devices market into
diagnostic devices, surgical devices, vision care and drugs. All these markets are broken down
into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012,
as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a
granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-
depth information on the global scenario. However, the drugs market is analyzed in the U.S.,
Europe, Japan, Asia, and Rest of the world.
Global ophthalmology market by products
•Diagnostic and monitoring devices
•Surgical devices
•Vision care
•Drugs
Diagnostic and monitoring devices
•Optical Coherence Tomographers (OCT)
•Ophthalmic ultrasound imaging systems
•Fundus cameras
•Ophthalmoscopes
•Retinoscopes
•Wavefront aberrometer
•Corneal topographer
•Autorefractors/Phoropters
•Pachymeters
•Keratometers
•Specular microscopes
•Biometers
•Visual field analysers/Perimeter
•Tonometers
•Slit lamps
•Optotype projectors
•Dioptometers
Vision care
3. •Contact lenses
•Spectacles
Surgical devices Market
Cataract
•Intraocular Lens (IOL)
•Ophthalmic Viscoelastic Devices (OVD)
•Phacoemulsification Devices
Glaucoma
•Glaucoma Drainage Devices (GDD)
•Stents and Implants
•Glaucoma Lasers
•Glaucoma Systems
Refractive error
•Excimer Laser
•YAG Laser
•Microkeratome
•Femtosecond Laser
Vitreoretinal
•Vitrectomy Machines
•Photocoagulation Lasers
•Illumination Devices
Global ophthalmology drugs market, by indication:
•Glaucoma
•Retinal disorders (Age-related Macular Degeneration (AMD), Diabetic retinopathy, Macular
edema)
•Dry eye
•Allergy/Inflammation/Conjunctivitis
The report does not include the following: The services and accessories market for ophthalmology
devices, consumables/disposables associated with the devices, and combination devices.
The report only covers those drugs that are in late Phase 3 or those that have cleared Phase 3
clinical trials for pipeline analysis and forecasting.
Ophthalmology devices market, by geography
•North America
•Europe
•Asia
•Rest of the World (RoW)
Ophthalmology drugs market, by geography
•U.S.
•Europe
4. •Asia
•Japan
•Rest of the World (RoW)
Get your copy of this report @
http://www.reportsnreports.com/reports/187192-ophthalmology-devices-and-drugs-market-contact-lens-oct-
scanner-iol-dry-eye-amd-glaucoma-competitive-landscape-global-forecasts-to-2017.html
Major points covered in Table of Contents of this report include
Table Of Contents
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 DETAILS OF PRIMARY INTERVIEWEES
1.5.6 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Aging population to propel the need for ophthalmology drugs and devices
3.3.1.2 Increasing prevalence rates of eye diseases is projected to fuel need for ophthalmology
products
3.3.1.3 Changing geographical trends and demographics to drive ophthalmology market
3.3.1.4 Increased focus on combination therapies present enormous prospect for ophthalmology
drugs
3.3.2 RESTRAINTS
3.3.2.1 Economic slowdown and saturation to inhibit the growth
3.3.2.2 Drying pipeline and major drugs going off-patent to affect the growth
3.3.3 OPPORTUNITIES
3.3.3.1 Intraocular lenses and phacoemulsification devices provide substantial opportunities in
emerging markets
5. 3.3.3.2 Untapped emerging markets present significant opportunities
3.4 MARKET SHARE ANALYSIS
3.4.1 OPHTHALMOLOGY SURGICAL DEVICES
3.4.2 OPHTHALMOLOGY DIAGNOSTIC AND MONITORING DEVICES
3.4.3 VISION CARE
3.4.4 OPHTHALMOLOGY DRUGS
4 GLOBAL OPHTHALMOLOGY DEVICES MARKET
4.1 INTRODUCTION
4.2 OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT MARKET
4.2.1 INTRODUCTION
4.2.2 MARKET DYNAMICS
4.2.2.1 Increasing demand for diagnostic procedure will propel market growth
4.2.2.2 Increased risk of ocular diseases due to aging to goad market growth
4.2.2.3 Technical advances increase market penetration of diagnostic devices
4.2.3 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS
4.2.4 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
4.2.5 FUNDUS CAMERA
4.2.6 OPHTHALMOSCOPES
4.2.7 RETINOSCOPE
4.2.8 WAVEFRONT ABERROMETERS
4.2.9 CORNEAL TOPOGHAPHERS
4.2.10 AUTOREFRACTORS/PHOROPTER
4.2.11 PACHYMETER
4.2.12 KERATOMETERS
4.2.13 SPECULAR MICROSCOPE
4.2.14 BIOMETERS
4.2.15 PERIMETERS/VISUAL FIELD ANALYSERS
4.2.16 TONOMETERS
4.2.17 SLIT LAMPS
4.2.18 OTHERS
4.3 OPHTHALMOLOGY SURGERY DEVICES MARKET
4.3.1 CATARACT SURGERY DEVICES
4.3.1.1 Drivers
4.3.1.1.1 Large pool of cataract patients impetus for growth of ophthalmic surgeries
4.3.1.1.2 Phacoemulsification technique to register highest growth in emerging countries
4.3.1.1.3 Multifocal ability of premium lenses creates major growth prospects for ophthalmic
market
4.3.1.2 Intraocular Lens (IOL)
4.3.1.3 Ophthalmic Viscoelastic Devices (OVD)
4.3.1.4 Phacoemulsification Devices
4.3.2 GLAUCOMA SURGERY DEVICES
6. 4.3.2.1 Drivers
4.3.2.1.1 Increase in glaucoma susceptible population to drive the surgery devices market
4.3.2.1.2 Increasing prevalence of obesity and diabetes resulting in rise of ophthalmic disorders
4.3.2.1.3 Low compliance with pharmaceuticals to propel the devices market
4.3.2.2 Restraint
4.3.2.2.1 Low awareness to hinder the growth of glaucoma surgical devices market
4.3.2.3 Glaucoma Drainage Devices (GDD)
4.3.2.4 Stents and Implants
4.3.2.5 Glaucoma Lasers
4.3.2.6 Glaucoma Systems
4.3.3 REFRACTIVE SURGERY DEVICES
4.3.3.1 Driver
4.3.3.1.1 High prevalence rates of refractive errors drive the refractive surgeries market
4.3.3.2 Restraint
4.3.3.2.1 No insurance coverage for refractive surgeries restrains the devices market
4.3.3.3 Excimer Laser
4.3.3.4 YAG Laser
4.3.3.5 Microkeratome
4.3.3.6 Femtosecond Laser
4.3.4 VITREORETINAL SURGERY DEVICES
4.3.4.1 Drivers
4.3.4.1.1 Increase in diabetic retinopathies increases demand for vitreoretinal surgeries
4.3.4.1.2 Rising prevalence of age-related macular degeneration (AMD) results in more
vitreoretinal surgeries
4.3.4.2 Vitrectomy Machines
4.3.4.3 Photocoagulation Lasers
4.3.4.4 Illumination devices
4.4 VISION CARE
4.4.1 CONTACT LENS
4.4.2 SPECTACLES
5 GLOBAL OPHTHALMOLOGY DRUG MARKET
5.1 INTRODUCTION
5.2 DRUG DELIVERY TYPES
5.2.1 CAPSULES & TABLETS
5.2.2 GELS
5.2.3 EYE DROPS
5.2.4 EYE OINTMENTS
5.2.5 EYE SOLUTIONS
5.3 GLAUCOMA
5.3.1 EXISTING
5.3.1.1 Xalatan (Latanoprost)/Xalacom (Latanoprost and Timolol combination) (Xalabrands)